PINK1

Jean-Ehrland Ricci presented research on PINK1-dependent mitophagy in lung cancer, examining how this cellular recycling process contributes to tumour development and shapes patient response to KRAS-targeted therapy. The findings suggest that mitophagy may influence how effectively KRAS-mutant lung cancers respond to targeted drugs, a key focus of current oncology research.